![](/img/cover-not-exists.png)
Hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy for the treatment of frail and/or elderly patients with locally advanced HNSCC: a phase I/II study
Le Tourneau, C., Calugaru, V., Borcoman, E., Moreno, V., Calvo, E., Liem, X., Salas, S., Doger, B., Jouffroy, T., Mirabel, X., Rodriguez, J., Chilles, A., Bernois, K., De Rink, M., Baskin-Bey, E., FakVolume:
106
Journal:
International Journal of Radiation Oncology*Biology*Physics
DOI:
10.1016/j.ijrobp.2019.11.207
Date:
April, 2020
File:
PDF, 329 KB
2020